Literature DB >> 22371291

Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer.

Noemí Eiró1, Lucía González, Luis O González, Alejandro Andicoechea, María Fernández-Díaz, Antonio Altadill, Francisco J Vizoso.   

Abstract

PURPOSE: Dysregulation of toll-like receptors (TLR) signaling can result in chronic inflammatory and over-exuberant repair responses. The aim of this study was to investigate the expression and clinical relevance of TLR in colorectal polyps.
METHODS: The expression levels of six TLR were analyzed in 70 patients with different histological types of colorectal polyps, 38 of which developed colorectal carcinoma (CC). These analyses were performed by real-time polymerase chain reaction, western blot, and immunohistochemistry.
RESULTS: TLR9 expression was higher in hyperplastic or adenomatous polyps compared to other polyp types. Hyperplastic polyps also showed increased TLR7 levels compared to the other polyp types. TLR7 expression was lower in both hyperplastic and tubulovillous adenoma polyps from patients who developed CC. TLR9 expression was decreased in hyperplastic and villous polyps from patients who developed CC.
CONCLUSIONS: Our findings suggest a possible protective role of TLR expression against malignant transformation in the colorectal mucosa. TLR may represent a pathological marker of CC risk in colorectal polyps. The role of these factors in the pathology of colorectal polyps deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371291     DOI: 10.1007/s10875-012-9666-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Does the amount of tagged stool and fluid significantly affect the radiation exposure in low-dose CT colonography performed with an automatic exposure control?

Authors:  Hyun Kyong Lim; Kyoung Ho Lee; So Yeon Kim; Kil Joong Kim; Bohyoung Kim; Hyunna Lee; Seong Ho Park; Jeffrey H Yanof; Seung-Sik Hwang; Young Hoon Kim
Journal:  Eur Radiol       Date:  2010-08-11       Impact factor: 5.315

Review 2.  TLR signaling.

Authors:  T Kawai; S Akira
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

3.  TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.

Authors:  Yiqun Zhang; Andrew S Lee; Afshin Shameli; Xuan Geng; Diane Finegood; Pere Santamaria; Jan P Dutz
Journal:  J Immunol       Date:  2010-04-14       Impact factor: 5.422

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.

Authors:  Fumio Omata; Gautam Deshpande; Yasuharu Tokuda; Osamu Takahashi; Sachiko Ohde; David L Carr-Locke; Joshua L Jacobs; Tetsuya Mine; Tsuguya Fukui
Journal:  J Gastroenterol       Date:  2010-04-07       Impact factor: 7.527

6.  Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps.

Authors:  A Liljegren; A Lindblom; S Rotstein; B Nilsson; C Rubio; E Jaramillo
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 7.  JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

Authors:  Tatiana R Coelho; Luis Almeida; Pedro A Lazo
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

8.  Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.

Authors:  Xian-Zhen Chen; Xiao-Hong Mao; Ke-Jian Zhu; Na Jin; Jun Ye; Jian-Ping Cen; Qiang Zhou; Hao Cheng
Journal:  Arch Dermatol Res       Date:  2009-07-04       Impact factor: 3.017

Review 9.  Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

Authors:  Maria T Abreu
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

10.  Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Authors:  S Escaff; J M Fernández; L O González; A Suárez; S González-Reyes; J M González; F J Vizoso
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

View more
  19 in total

1.  Toll-like receptor expression pattern: clinical application.

Authors:  Shirin Moossavi; Nima Rezaei
Journal:  J Clin Immunol       Date:  2012-06-19       Impact factor: 8.317

Review 2.  Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.

Authors:  Srikanth Santhanam; David M Alvarado; Matthew A Ciorba
Journal:  Transl Res       Date:  2015-08-03       Impact factor: 7.012

Review 3.  Immunotherapy in colorectal cancer: for the select few or all?

Authors:  Sukeshi Patel Arora; Devalingam Mahalingam
Journal:  J Gastrointest Oncol       Date:  2018-02

Review 4.  Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.

Authors:  Ting-Ting Li; Shuji Ogino; Zhi Rong Qian
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  The expression profiles of chemokines, innate immune and apoptotic genes in tumors caused by Rous Sarcoma Virus (RSV-A) in chickens.

Authors:  Vishwa M Khare; Vishesh K Saxena; Mariah A Pasternak; Angelique Nyinawabera; Kunwar B Singh; Charles R Ashby; Amit K Tiwari; Yuan Tang
Journal:  Genes Immun       Date:  2021-12-21       Impact factor: 2.676

Review 6.  The emerging role of immunotherapy in colorectal cancer.

Authors:  David Lynch; Adrian Murphy
Journal:  Ann Transl Med       Date:  2016-08

7.  Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells.

Authors:  Jiong Jiang; Lei Dong; Bin Qin; Haitao Shi; Xiaoyan Guo; Yan Wang
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

Review 8.  Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects.

Authors:  István Fűri; Ferenc Sipos; Tiana M Germann; Alexandra Kalmár; Zsolt Tulassay; Béla Molnár; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

9.  Expression of toll-like receptors on human rectal adenocarcinoma cells.

Authors:  Marcin Tchórzewski; Przemysław Lewkowicz; Adam Dziki; Henryk Tchórzewski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-01-05       Impact factor: 4.291

Review 10.  Trial Watch: Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-06-10       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.